| Michael E Knower, MD | |
|
2275 Ne Doctors Dr, Suite 3, Bend, OR 97701-6324 | |
| (541) 706-6700 | |
| (541) 706-5996 |
| Full Name | Michael E Knower |
|---|---|
| Gender | Male |
| Speciality | Family Medicine - Hospice And Palliative Medicine |
| Location | 2275 Ne Doctors Dr, Bend, Oregon |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134111909 | NPI | - | NPPES |
| 218722 | Medicaid | OR | |
| 113411909 | Other | OR | NPI |
| Mailing Address | Practice Location Address |
|---|---|
| Michael E Knower, MD 2275 Ne Doctors Dr, Suite 3, Bend, OR 97701-6324 Ph: (541) 706-6700 | Michael E Knower, MD 2275 Ne Doctors Dr, Suite 3, Bend, OR 97701-6324 Ph: (541) 706-6700 |
News Archive
Obesity is a serious health problem affecting approximately one-third of the adult population in the United States. Obese individuals have an increased risk of diabetes and cardiovascular disease, including hypertension. A recent study led by a University of Missouri researcher has identified the enzyme responsible for obesity-related hypertension - a finding that could lead to new treatment options.
Sunesis Pharmaceuticals, Inc. today announced the closing of a private placement of $5.0 million of units consisting of convertible preferred stock and common stock warrants on October 30, 2009. This closing constitutes the second tranche of the private placement of up to $43.5 million of Sunesis' securities announced in April 2009.
Indiana University School of Medicine researchers are participating in the Rare and Atypical Diabetes Network (RADIANT), a nationwide study funded by the National Institutes of Health. The study seeks to discover new forms of diabetes, identify their causes, and understand how they differ from more common types of diabetes.
Researchers at The Cancer Institute of New Jersey (CINJ) have opened a clinical trial, which aims to evaluate a new treatment for solid cancer tumors and non-Hodgkin's lymphoma (NHL) in combination with a chemotherapy agent called cyclophosphamide.
Dr. Jim Evans, an expert in gene patenting and genetics policy who has led a program to educate federal judges about the intricacies of genetics and genetic policy, says the ruling by United States District Court Judge Robert Sweet that invalidated seven patents related to the BRCA 1 and BRCA 2 genes "came as a surprise to everybody. It's really quite unusual for plaintiffs to get a summary judgment."
› Verified 2 days ago
Wendy Yerington Dryden, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2577 Ne Courtney Dr Ste 100, Bend, OR 97701 Phone: 541-383-3005 Fax: 541-383-1883 | |
Lisa Kristine Mizeur, FNP Family Medicine Medicare: Medicare Enrolled Practice Location: 2600 Ne Neff Rd, Bend, OR 97701 Phone: 541-706-4800 Fax: 541-706-4806 | |
William B Wignall, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1247 Ne Medical Center Dr, Bend, OR 97701 Phone: 541-318-4249 | |
Edward M Tarbet, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1501 Ne Medical Center Dr, Bend, OR 97701 Phone: 541-382-2811 Fax: 541-317-4588 | |
Michael R. Hudson, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2600 Ne Neff Rd, Bend, OR 97701 Phone: 541-706-3700 Fax: 541-706-3730 | |
Dr. Michelle Ann Kyriakos, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1375 Nw Kingston Ave, Bend, OR 97701 Phone: 541-383-5958 Fax: 541-383-3016 | |
Dr. Laura Kay Pennavaria, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 568 Ne Savannah Dr, Bend, OR 97701 Phone: 541-516-1705 Fax: 541-833-2619 |